Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Changes in cross-sectional area of pulmonary vessels on chest computed tomography after chemotherapy in patients with advanced non-squamous non-small-cell lung cancer.
Karayama M, Inui N, Kusagaya H, Suzuki S, Inoue Y, Enomoto N, Fujisawa T, Nakamura Y, Suda T. Karayama M, et al. Among authors: fujisawa t. Cancer Chemother Pharmacol. 2016 May;77(5):1011-8. doi: 10.1007/s00280-016-3017-7. Epub 2016 Mar 31. Cancer Chemother Pharmacol. 2016. PMID: 27034279
Gastrointestinal Bleeding From Duodenal Aberrant Pancreas After Antiangiogenic Therapy.
Nishimoto K, Karayama M, Akiyama N, Suzuki S, Inoue Y, Kono M, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T. Nishimoto K, et al. Among authors: fujisawa t. J Clin Gastroenterol. 2016 Sep;50(8):689-90. doi: 10.1097/MCG.0000000000000561. J Clin Gastroenterol. 2016. PMID: 27306939 No abstract available.
Synchronous Duodenal Cancer and Lung Cancer Harboring an Epidermal Growth Factor Receptor Mutation Treated with Erlotinib and Oral Fluoropyrimidine.
Akiyama N, Karayama M, Iwaizumi M, Kusama Y, Kono M, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T. Akiyama N, et al. Among authors: fujisawa t. Intern Med. 2017 Sep 1;56(17):2367-2371. doi: 10.2169/internalmedicine.8312-16. Epub 2017 Aug 10. Intern Med. 2017. PMID: 28794362 Free PMC article.
Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II study.
Nishimoto K, Karayama M, Inui N, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inami N, Matsuura S, Kaida Y, Matsui T, Asada K, Matsuda H, Fujii M, Toyoshima M, Imokawa S, Suda T. Nishimoto K, et al. Among authors: fujisawa t. Med Oncol. 2018 Jun 16;35(7):108. doi: 10.1007/s12032-018-1172-x. Med Oncol. 2018. PMID: 29909581 Clinical Trial.
An Acquired Epidermal Growth Factor Receptor T790M Mutation after the Addition of Bevacizumab to Preceding Erlotinib Monotherapy in a Lung Cancer Patient with Leptomeningeal Metastases.
Tsuchiya K, Karayama M, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T. Tsuchiya K, et al. Among authors: fujisawa t. Intern Med. 2018 Dec 1;57(23):3423-3427. doi: 10.2169/internalmedicine.1062-18. Epub 2018 Aug 10. Intern Med. 2018. PMID: 30101917 Free PMC article.
Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis.
Hozumi H, Fujisawa T, Nakashima R, Yasui H, Suzuki Y, Kono M, Karayama M, Furuhashi K, Enomoto N, Inui N, Nakamura Y, Mimori T, Suda T. Hozumi H, et al. Among authors: fujisawa t. J Rheumatol. 2019 May;46(5):509-517. doi: 10.3899/jrheum.180778. Epub 2019 Jan 15. J Rheumatol. 2019. PMID: 30647164
Olanzapine-containing antiemetic therapy for the prevention of carboplatin-induced nausea and vomiting.
Tanaka K, Inui N, Karayama M, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Kusagaya H, Matsuura S, Uto T, Hashimoto D, Matsui T, Asada K, Suda T. Tanaka K, et al. Among authors: fujisawa t. Cancer Chemother Pharmacol. 2019 Jul;84(1):147-153. doi: 10.1007/s00280-019-03868-5. Epub 2019 May 13. Cancer Chemother Pharmacol. 2019. PMID: 31087137 Clinical Trial.
2,167 results